Core Concepts
AI has the potential to revolutionize cardiovascular imaging by adding value at every step of the patient journey.
Abstract
The American Heart Association (AHA) released a scientific statement highlighting the significant role of artificial intelligence (AI) in cardiovascular imaging. The statement, "Value Creation Through Artificial Intelligence and Cardiovascular Imaging," emphasizes the potential of AI to enhance cardiac imaging processes, from test selection to risk prediction for adverse cardiac events. Key insights include the diverse applications of AI tools in cardiac imaging, the importance of considering value creation when adopting AI tools, and the collaborative efforts needed from various stakeholders for successful AI deployment in clinical settings.
Key Highlights:
AI can enhance cardiac imaging processes at every step of the patient journey.
Multiple machine learning and AI tools are being developed for cardiovascular imaging.
Current AI applications in cardiac imaging are primarily based on CT and ultrasound.
Collaboration among clinicians, imagers, hospitals, patients, AI developers, and payers is crucial for successful AI deployment in clinical settings.
Stats
"As of April 2023, there are 46 applications cleared by the US Food and Drug Administration for cardiac imaging."
"Most current commercially available AI applications are based on CT and ultrasound."
Quotes
"AI is applicable and has the potential to add value to cardiac imaging at every step along the patient journey." - Kate Hanneman, MD, MPH